预防医疗决策:为什么70%的心脑血管支出本可避免

不是预防没价值,而是"预防结果无法被结算"。这句话背后是一个系统性困境,也是 ReHealth AI 存在的根本原因。

在中国,心脑血管疾病是导致死亡的第一大原因,每年直接医疗支出超过3000亿元。但在这个数字背后,有一个残酷的现实:70%以上的支出,发生在本可提前3-5年有效干预的阶段。

这不是医生的失职,也不是患者的疏忽,而是一个系统性的结构失灵。

70%
心脑血管医疗支出
发生在可干预阶段之后
3-5年
风险信号可以
提前被识别的窗口期
¥0
预防行为获得的
医疗支付方报销

预防医疗为什么始终停留在口号层面

我们来看一个具体的场景:一位45岁的中年男性,体检发现血压偏高、BMI超标、有家族心脏病史。医生建议他改变生活方式,定期监测。他照做了——坚持运动、控制饮食、每月复查。三年后,他的各项指标都明显改善,心脑血管发病风险大幅降低。

这是一个医学上的成功故事。但在现有的医疗支付体系里,这件事对任何人都没有经济价值。

核心困境
保险公司无法为"没有发生的疾病"付费。医院无法为"预防行为"收费。医生无法证明"正是这次干预避免了发病"。所有参与者都知道预防有价值,但没有人能从中获得回报。

四个现有方案为什么注定失败

📱

健康管理 App

能记录行为,但无法证明临床效果。支付方不认可没有临床证据的数据。

🤖

医疗 AI 平台

只预测风险,不管理干预,不对结果归因。预测了风险但证明不了预防效果。

可穿戴设备

有连续的生理数据,但零因果分析。数据多不等于能证明干预有效。

💬

通用 AI

不合规、不可信、不可审计。医疗场景需要临床级证据,通用AI无法提供。

这四类方案的共同缺陷是:它们都缺乏"长期健康记忆 + 干预因果评估"这两个核心能力。 没有长期健康记忆,就无法建立个体风险基线。没有因果评估,就无法证明干预改变了风险轨迹。

真正的解法需要跑通一个完整闭环

ReHealth AI 的核心判断是:预防医疗的结算问题,本质上是一个证据生产问题。只要能生产出支付方认可的因果证据,结算自然就能发生。

01

风险演进建模(预测未来)

基于多模态时序数据,建立个体健康轨迹模型,提前3-5年识别心脑血管高风险信号。这不是简单的统计评分,而是对风险演进路径的动态建模。

02

个性化干预(改变轨迹)

基于个体健康档案,生成针对性的干预方案。不是通用的"多运动少吃盐",而是根据这个人的具体风险因子定制的干预路径。

03

因果归因分析(证明有效)

用PSM倾向性得分匹配法,对比"接受干预"和"未接受干预"的相似患者群体,统计验证干预是否真的改变了风险轨迹。这是生产临床可接受证据的关键。

04

预防结算(变现证据)

将因果证据提交给保险公司或医疗机构,使其能够为"已证明有效的预防结果"付费。预防第一次变得可以被结算。

为什么聚焦心脑血管疾病

心脑血管疾病是验证这套体系的最佳起点,原因很具体:它是中国患病人数最多、死亡率最高的慢性病;其主要风险因子(高血压、血脂异常、糖尿病、肥胖)都是可以通过干预改变的;从风险暴露到发病之间有足够长的时间窗口,让预防干预有施展空间;发病与否是可以客观确认的终点事件,方便进行因果验证。

✓ 核心逻辑

用一个专病(心脑血管),跑通"预测 → 干预 → 归因 → 结算"的完整闭环。一旦这个闭环跑通,同样的基础设施可以扩展到其他慢性病领域——糖尿病、慢阻肺、肾病……

这不是技术问题,是基础设施问题

ReHealth AI 的定位不是"又一个医疗AI",而是预防医疗的决策基础设施。就像金融领域需要清算系统才能让交易结算,预防医疗需要一套能生产因果证据、被支付方认可的基础设施,才能让预防结果结算。

这套基础设施的核心不是预测准确率,而是因果证据的生产能力——这也是 ReHealth AI 与其他医疗AI产品最根本的区别。

了解 ReHealth Core 如何跑通预防闭环

我们向符合资质的医疗机构、保险公司和企业健康管理方开放 API 试用。亲自审核每一份申请。

申请 API 访问 →

Preventive Medicine: Why 70% of Cardiovascular Costs Are Avoidable

Prevention has value. It just can't be billed. Behind this sentence lies a systemic failure — and the fundamental reason ReHealth AI exists.

In China, cardiovascular disease is the leading cause of death, with direct medical spending exceeding 300 billion yuan annually. But behind this number lies a brutal reality: over 70% of this spending occurs at stages where effective intervention was possible 3-5 years earlier.

This isn't physician negligence or patient carelessness — it's a systemic structural failure.

70%
Cardiovascular spending occurring after the intervention window closes
3-5 yr
Window during which risk signals can be identified in advance
¥0
Reimbursement received by payers for preventive actions

Why Preventive Medicine Stays at the Slogan Level

Consider a concrete scenario: a 45-year-old man discovers elevated blood pressure, high BMI, and family history of heart disease during a checkup. His doctor recommends lifestyle changes and regular monitoring. He follows through — consistent exercise, dietary control, monthly checkups. Three years later, his indicators improve significantly and his cardiovascular risk drops substantially.

This is a medical success story. But in the current payment system, this accomplishment has zero economic value for anyone involved.

Core Dilemma
Insurers can't pay for "diseases that didn't happen." Hospitals can't charge for "preventive behavior." Physicians can't prove "this specific intervention prevented the disease." Everyone knows prevention has value, but no one can profit from it.

Why Four Existing Solutions All Fall Short

📱

Health Apps

Record behavior but can't prove clinical outcomes. Payers don't accept data without clinical evidence.

🤖

Medical AI Platforms

Only predict risk, don't manage interventions or attribute outcomes. Risk prediction alone can't prove prevention effectiveness.

Wearable Devices

Continuous physiological data with zero causal analysis. More data doesn't equal proven intervention effectiveness.

💬

General AI

Non-compliant, untrustworthy, non-auditable. Medical contexts require clinical-grade evidence that general AI cannot provide.

The shared deficiency: all four lack two core capabilities: long-term health memory and intervention causal evaluation. Without long-term health memory, you can't establish individual risk baselines. Without causal evaluation, you can't prove intervention changed the risk trajectory.

The Real Solution Requires a Complete Closed Loop

01

Risk Trajectory Modeling (Predict the Future)

Using multimodal time-series data to build individual health trajectory models, identifying cardiovascular high-risk signals 3-5 years in advance — dynamic modeling of risk evolution, not simple statistical scoring.

02

Personalized Intervention (Change the Trajectory)

Generate targeted intervention plans based on individual health profiles — not generic "exercise more, eat less salt," but intervention pathways customized to this person's specific risk factors.

03

Causal Attribution Analysis (Prove Effectiveness)

Using Propensity Score Matching (PSM) to compare similar patient groups who did and didn't receive interventions, statistically verifying whether the intervention actually changed the risk trajectory — the key to producing clinically acceptable evidence.

04

Prevention Settlement (Monetize Evidence)

Submit causal evidence to insurers or medical institutions, enabling them to pay for "proven effective prevention outcomes." For the first time, prevention becomes billable.

✓ Core Logic

Use one disease (cardiovascular) to run the complete "predict → intervene → attribute → settle" closed loop. Once this loop works, the same infrastructure can expand to other chronic disease domains — diabetes, COPD, kidney disease...

Learn How ReHealth Core Closes the Prevention Loop

We open API access to qualified healthcare institutions, insurers, and enterprise health management partners. Every application is personally reviewed.

Apply for API Access →